BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T132000
DTEND;TZID=America/New_York:20220602T154500
DTSTAMP:20220601T173444Z
CREATED:20220601T173444Z
LAST-MODIFIED:20220601T173444Z
UID:55587-1654176000-1654184700@globalbiodefense.com
SUMMARY:Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape
DESCRIPTION:The National Academies’ Board on Life Sciences is pleased to present two discussions – Bioeconomy of the Future and Changing Landscape of Life Science Research Laboratories – to explore critical and emerging issues with the bioeconomy and privately-sponsored basic life sciences research. \nThe life sciences research landscape is changing rapidly as new investments in the bioeconomy drive convergence among science and technology fields to develop new products and services\, and as basic research laboratories are established by private investors. \nThe Bioeconomy of the Future will explore: \n\nChanges that have taken place since publication of the National Bioeconomy Blueprint (2012)\, Safeguarding the Bioeconomy (2020)\, and The Bio Revolution: Innovations Transforming Economies\, Societies\, and our Lives (2020)\nImmediate and near-term developments associated with the bioeconomy\nFuture needs for realizing the full potential of the bioeconomy\nOutstanding needs for protecting and promoting the bioeconomy long-term\n\nFeatured Speakers \n\nMary Maxon\, Schmidt Futures\nAndrea Hodgson\, Schmidt Futures\nMichael Chui\, McKinsey & Company\n\nThe Changing Landscape of Life Sciences Research Laboratories will explore: \n\nShifts in the landscape of life sciences research based on the emergence of research institutes funded by for-profit companies\nThe benefits to the shifting life sciences research landscape\nPossible trade-offs related to life sciences research that are conducted at for-profit institutions\nEmerging trends in life science research landscape and how they relate to current and future public policy\nFuture workforce needs and how education might change to support these new institutions\n\nPlease visit the National Academies’ Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape event page for more information.
URL:https://globalbiodefense.com/event/future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://www.nationalacademies.org/event/06-02-2022/board-on-life-sciences-open-webinar-future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T180000
DTEND;TZID=America/New_York:20220608T180000
DTSTAMP:20220527T184920Z
CREATED:20220527T184920Z
LAST-MODIFIED:20220527T184920Z
UID:55106-1654711200-1654711200@globalbiodefense.com
SUMMARY:GMU Schar School of Policy and Government Virtual Open House
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will host a Master’s and Certificate Virtual Open House on June 8\, 2022 from 6:00 pm – 8:00 pm. \nThe event will provide an overview of available master’s degree programs and highlight GMU’s world-class faculty and research. Admissions and student services staff will be on hand to answer questions. \nThis event is the perfect opportunity to: \n\nExplore Schar School’s top-ranked master’s degree and graduate certificate programs\nLearn about your program of interest in depth\, including the curriculum\, admissions requirements\, and career opportunities\nAsk admissions team members specific questions about the application process\n\nBreakout sessions hosted by program directors and faculty will be available based on your primary program of interest: \nMaster’s in Biodefense\nMaster’s in International Commerce and Policy\nMaster’s in International Security\nMaster’s in Organization Development and Knowledge Management\nMaster’s in Political Science\nMaster’s in Public Administration (MPA)\nMaster’s in Public Policy (MPP) \nBiodefense Certificate\nEmergency Management and Homeland Security Certificate\nGlobal Health and Security Certificate\nIllicit Trade Analysis Certificate\nNational Security and Public Policy Certificate\nNonprofit Management Certificate\nPublic Management Certificate\nScience\, Technology\, and Security Certificate\nStrategic Trade Certificate\nTerrorism and Homeland Security Certificate \nFind more information and register to attend here. \nGlobal Biodefense is an official media partner of the GMU Schar School Biodefense program.
URL:https://globalbiodefense.com/event/gmu-schar-school-of-policy-and-government-virtual-open-house/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/05/schar-school-open-house-june-2022.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220609
DTEND;VALUE=DATE:20220614
DTSTAMP:20240623T192335Z
CREATED:20210925T163351Z
LAST-MODIFIED:20240623T192335Z
UID:49843-1654732800-1655164799@globalbiodefense.com
SUMMARY:ASM Microbe 2022
DESCRIPTION:ASM Microbe 2022 will be held 9-13 June 2022 in Washington\, D.C. \nASM Microbe 2022 will also include a virtual component providing access to scientific programming and accommodating those who are unable or do not wish to attend in-person. Get details on the digital experience. \nAntimicrobial agents and resistance\, biofilms\, HAIs\, diagnostic immunology\, antifungal agents\, and pharmacological studies of antimicrobial agents are just some of the core topics covered in this can’t-miss event. \nHighlighted sessions and topics include: \n\nNGS for Near Real-Time Surveillance and Outbreak Response by Public Health and Clinical Labs\nPublic Health Implications of Fungal Diseases: It’s Time for Action\nUse of Human Organ-on-Chip and Organoid Platforms in Acute Viral Disease\nIn-depth Symposium. AAR14M. One Health Right Now\nTick\, Talk\, Boom: Newly Emerging Tick-Transmitted Disease\nPre-Term and Pediatric Infections: How to Prevent and How to Treat\nCrossing the Threshold: Pros and Cons of Reporting Cycle Threshold Values\nWastewater-based Epidemiology: SARS-CoV-2 and Other Emerging Pathogens\nFungi Enter the AMR Arena\nUsing Protein Structure Prediction Algorithms\nThe Pre-clinical Antimicrobial Pipeline: What is Really New?\nHistopathology of Infectious Diseases for Clinical Microbiologists\nParasites\, Global Health and Novel Pathogens: My Journey as a Clinical Microbiologist\nUpdate on Rapid Diagnostics in Infectious Diseases\nAvoiding Dogmas and Pitfalls in Clinical Parasitology\nAdaptation of Mouse Models for Human Adapted Pathogens\nCurrent Status of Vaccine Research and Development for Clostridioides difficile\nLaboratory diagnostics for invasive fungal infections with a focus on immunocompromised hosts\nI Can’t Take This Anymore–Taxonomic Changes in Microbiology (Can We Find Common Ground?)\nOld Foes\, New Horizons: Updates and Innovations in Malaria and Polio Vaccines\nScience Communication: Combating Vaccine Hesitancy\nChallenging Gram-positive Clinical Cases for Application of New Agents\nMicrobiology in Space: Moving Beyond Low Earth Orbit to the Moon and Mars\nVerification and Validation of Microbiology Tests: Tackling the Who\, What\, When\, Why and HOW?\nBacterial Integration of Host Microbiota Cues Regulate Fitness and Virulence\nThe Pandemic Response in Developing Nations: TB Re-emergence and Other Unexpected Challenge\nDrug Resistance and Diarrheal Disease in the Developing World\nPlastics\, Metals and Other Contaminants as AMR Hotspots and Transporters\nPathogens and Pest Control in Agriculture\nMicrobiomes of Livestock in Food Systems: Emerging Pathogens\, Probiotics and Alternatives to Antibiotics\nNew Agents Discovery Summary Session: Early New Antimicrobial Agents\nMicrobiology and Stewardship Lessons Learned During the COVID-19 Pandemic\n\n Please visit the ASM Microbe website for more information.
URL:https://globalbiodefense.com/event/asm-microbe-2022/
LOCATION:Washington DC Area\, Washington\, DC\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T083000
DTEND;TZID=America/New_York:20220614T170000
DTSTAMP:20220527T205853Z
CREATED:20220527T205356Z
LAST-MODIFIED:20220527T205853Z
UID:55113-1655195400-1655226000@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Moderna Pediatric (Ages 6-17) mRNA Vaccine EAU
DESCRIPTION:The VRBPAC committee will meet in open session on June 14\, 2022 to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904 \nOn June 15\, 2022\, under Topic II\, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \n  \n  \n 
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-moderna-pediatric-ages-6-17-mrna-vaccine-eau/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=GbNpaZeDPiA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220615T083000
DTEND;TZID=America/New_York:20220615T170000
DTSTAMP:20220527T210409Z
CREATED:20220527T210409Z
LAST-MODIFIED:20220527T210409Z
UID:55115-1655281800-1655312400@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Pediatric (Infant - 5 Years) mRNA Vaccines
DESCRIPTION:The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904.
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-pediatric-infant-5-years-mrna-vaccines/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=Ixm4UmldTGQ
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220619
DTEND;VALUE=DATE:20220624
DTSTAMP:20210226T210720Z
CREATED:20210226T210720Z
LAST-MODIFIED:20210226T210720Z
UID:48681-1655596800-1656028799@globalbiodefense.com
SUMMARY:ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases
DESCRIPTION:Discover the latest achievements in the fight against the pneumococcus at the ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases 19-23 June 2022 in Toronto. \nThis meeting was originally scheduled for Oct 2020. Given on-going safety concerns for in-person meetings due to COVID-19 during 2020-2021\, the in-person event was ultimately pushed to June 2022. \nThe event brings together professionals in the field to raise global awareness and improve standards of diagnosis\, prevention and treatment. \nHighlighted topics include: \n\nEpidemics\, outbreaks\, and special settings\nPneumococcal epidemiology\nVaccine effect on disease in children\nTrends in non-vaccine serotypes\nMathematical modeling\nDiagnosis and diagnostic assays\nAntimicrobial resistance\nConventional and molecular microbiology\nTreatment of pneumonia and pneumococcal disease\nGenetic sequencing\nPneumococcal colonization\nAdult vaccination strategies\nIndirect effects of paediatric programmes on disease in adults\nPneumococcal disease in persons with high-risk conditions\nPneumococcal vaccines in development\nCOVID effects on pneumonia and pneumococcal disease burden\nEffects of COVID on pneumoccoccal vaccine programmes\nManagement of community acquired pneumonia in the time of COVID\nEmerging data on SARS-CoV2 and pneumococcus interaction\n\nPlease visit the ISPPD-12 website for more information on how to participate.
URL:https://globalbiodefense.com/event/isppd-12-international-symposium-on-pneumococci-and-pneumococcal-diseases/
LOCATION:Sheraton Centre Toronto Hotel\, 123 Queen St W\, Toronto\, Ontario\, M5H 2M9
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220628T083000
DTEND;TZID=America/New_York:20220628T170000
DTSTAMP:20220527T213139Z
CREATED:20220527T213139Z
LAST-MODIFIED:20220527T213139Z
UID:55118-1656405000-1656435600@globalbiodefense.com
SUMMARY:VRBPAC Meeting on COVID-19 Vaccine Strain Composition Decisions
DESCRIPTION:The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. \nThe Docket Number is FDA-2022-N-0905
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-covid-19-vaccine-strain-composition-decisions/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=BFdzNUus_CE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220629T120000
DTEND;TZID=America/New_York:20220629T170000
DTSTAMP:20220622T153805Z
CREATED:20220622T153805Z
LAST-MODIFIED:20220622T153805Z
UID:55703-1656504000-1656522000@globalbiodefense.com
SUMMARY:USG Policies for the Oversight of Life Sciences Dual Use Research of Concern
DESCRIPTION:The purpose of this meeting is to gather feedback from stakeholders about their experiences implementing these policies\, the effect of these policies in terms of achieving their stated goals\, the overarching definition of DURC\, and possible alternative approaches for the oversight and responsible conduct of DURC. \nThis feedback will also be used to inform the discussions of the National Science Advisory Board for Biosecurity (NSABB) in fulfillment their current charge to evaluate and analyze the DURC policies. \nRegistration is not required to view the webcast. \nREAD MORE: Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
URL:https://globalbiodefense.com/event/usg-policies-for-the-oversight-of-life-sciences-dual-use-research-of-concern/
CATEGORIES:Conference,Government Hosted
LOCATION:https://osp.od.nih.gov/event/virtual-stakeholder-engagement-meeting-on-usg-policies/
END:VEVENT
END:VCALENDAR